Review



ccrf hsb 2  (Korean Cell Line Bank)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Korean Cell Line Bank ccrf hsb 2
    Ccrf Hsb 2, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/acute+ccrf+cell+hsb2+leukemia+line/pmc12491253-42-0-1
    Average 86 stars, based on 1 article reviews
    ccrf hsb 2 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Fine-tuning signal strength in CD5 CAR-NK cells for targeted T cell cancer therapy
    Article Snippet: The human leukemia cell lines, MOLT4 (ATCC, CRL-1582), Jurkat (ATCC, TIB-152), CCRF-CEM (KCLB, 10119) and U937 (ATCC, CRL-1593.2), were cultured in RPMI1640 (Welgene) supplemented with 10% FBS and 1% PS. .. CCRF-HSB-2 (KCLB, 10120.1) and HEK293T (ATCC, CRL-3216) was cultured in DMEM (Welgene) supplemented with 10% FBS and 1% PS. ..



    Similar Products

    cd4 hsb 2  (ATCC)
    94
    ATCC cd4 hsb 2
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Cd4 Hsb 2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/pmc12951662-53-7-40
    Average 94 stars, based on 1 article reviews
    cd4 hsb 2 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cell culture 100 ccrf hsb 2  (ATCC)
    94
    ATCC cell culture 100 ccrf hsb 2
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Cell Culture 100 Ccrf Hsb 2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/pm41570879-50-1-5
    Average 94 stars, based on 1 article reviews
    cell culture 100 ccrf hsb 2 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human hsb 2  (ATCC)
    94
    ATCC human hsb 2
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Human Hsb 2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/pm41413567-67-1-37
    Average 94 stars, based on 1 article reviews
    human hsb 2 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    ccrf hsb 2  (Korean Cell Line Bank)
    86
    Korean Cell Line Bank ccrf hsb 2
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Ccrf Hsb 2, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/acute+ccrf+cell+hsb2+leukemia+line/pmc12491253-42-0-1
    Average 86 stars, based on 1 article reviews
    ccrf hsb 2 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    ccrf hsb 2  (ATCC)
    94
    ATCC ccrf hsb 2
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Ccrf Hsb 2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/us12415867-282-91-94
    Average 94 stars, based on 1 article reviews
    ccrf hsb 2 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human ccrf hsb 2 t lymphoblast cells  (ATCC)
    94
    ATCC human ccrf hsb 2 t lymphoblast cells
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Human Ccrf Hsb 2 T Lymphoblast Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/bio_rxiv__2025__06__04__652236-114-0-5
    Average 94 stars, based on 1 article reviews
    human ccrf hsb 2 t lymphoblast cells - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    cell lines  (ATCC)
    94
    ATCC cell lines
    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human <t>CD4</t> protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).
    Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ccrf+hsb+2/CCRF-HSB-2/pm39769333-249-1-10
    Average 94 stars, based on 1 article reviews
    cell lines - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human CD4 protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: (A) Schematic representation of aptamer–lipid nanoparticle (LNP) formulation using a microfluidic device, followed by thiol–aptamer conjugation. (B) Hydrodynamic size and (C) polydispersity index (PDI) of MC3- and SM102-based LNPs, either non-targeting or Apt62-modified. (D) Schematic illustrating molecular beacon hybridization assay for quantifying aptamer density on LNPs. (E) Thermal melt curves of Apt62 molecular beacons at concentrations ranging from 0 to 800 nM. (F) Biolayer interferometry (BLI) sensograms of Apt62 binding to recombinant human CD4 protein. (G) BLI sensograms of Apt62-functionalized LNPs binding to recombinant human CD4 protein. Data represent mean±SD ( n = 3 for B–C).

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Formulation, Conjugation Assay, Modification, Hybridization, Binding Assay, Recombinant

    Evaluation of cytotoxicity of aptamer-functionalized lipid nanoparticles (LNPs). Cell viability was measured following treatment with increasing doses of luciferase mRNA-loaded LNPs formulated with either MC3 or SM102 ionizable lipids. (A) SUP-T1 cells and (B) HSB-2 cells were incubated with non-targeting LNPs or Apt62-modified LNPs for 24 hours. Data represent mean±SD ( n = 4).

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: Evaluation of cytotoxicity of aptamer-functionalized lipid nanoparticles (LNPs). Cell viability was measured following treatment with increasing doses of luciferase mRNA-loaded LNPs formulated with either MC3 or SM102 ionizable lipids. (A) SUP-T1 cells and (B) HSB-2 cells were incubated with non-targeting LNPs or Apt62-modified LNPs for 24 hours. Data represent mean±SD ( n = 4).

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Luciferase, Incubation, Modification

    (A) eGFP expression in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells following treatment with mRNA-loaded LNPs formulated with MC3 or SM102, either non-targeting, Apt62-modified (25:1 or 100:1), or anti-human CD4 mAb-conjugated. (B) Representative flow cytometry histograms showing eGFP signal in live, singlet-gated in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells that were untreated (non-transfected) or treated with SM102-Apt62:100 or SM102 anti-human CD4 mAb-modified LNPs. (C) Quantification of mean fluorescence intensity (MFI) of SUP-T1 (CD4⁺) and HSB2 (CD4⁻) populations corresponding to panel (B). Data represent mean±SD ( n = 4). Statistical significance was determined using two-way ANOVA followed by Tukey's multiple comparisons test; **** p < 0.0001, *** p < 0.001, ** p < 0.01, ####p < 0.0001 versus corresponding CD4⁺ population.

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: (A) eGFP expression in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells following treatment with mRNA-loaded LNPs formulated with MC3 or SM102, either non-targeting, Apt62-modified (25:1 or 100:1), or anti-human CD4 mAb-conjugated. (B) Representative flow cytometry histograms showing eGFP signal in live, singlet-gated in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells that were untreated (non-transfected) or treated with SM102-Apt62:100 or SM102 anti-human CD4 mAb-modified LNPs. (C) Quantification of mean fluorescence intensity (MFI) of SUP-T1 (CD4⁺) and HSB2 (CD4⁻) populations corresponding to panel (B). Data represent mean±SD ( n = 4). Statistical significance was determined using two-way ANOVA followed by Tukey's multiple comparisons test; **** p < 0.0001, *** p < 0.001, ** p < 0.01, ####p < 0.0001 versus corresponding CD4⁺ population.

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Expressing, Modification, Flow Cytometry, Transfection, Fluorescence

    (A) Representative ex vivo IVIS images of major organs collected 6 h post-injection from mice treated with saline, MC3 or SM102 LNPs (non-targeting or Apt62:75), or SM102 anti-mouse/human CD4 mAb-conjugated LNPs. (B) Quantification of normalized luminescence in the liver. (C) Quantification of normalized luminescence in spleen. (D) Percentage of spleen-to-liver luminescence ratio. Data represent mean±SD ( n = 4). Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test; **** p < 0.0001, *** p < 0.001, ** p < 0.01.

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: (A) Representative ex vivo IVIS images of major organs collected 6 h post-injection from mice treated with saline, MC3 or SM102 LNPs (non-targeting or Apt62:75), or SM102 anti-mouse/human CD4 mAb-conjugated LNPs. (B) Quantification of normalized luminescence in the liver. (C) Quantification of normalized luminescence in spleen. (D) Percentage of spleen-to-liver luminescence ratio. Data represent mean±SD ( n = 4). Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test; **** p < 0.0001, *** p < 0.001, ** p < 0.01.

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Ex Vivo, Injection, Saline

    Assessment of organ indices and systemic cytokine markers 6 h postinjection. (A) Liver-to-body weight ratio. (B) Spleen-to-body weight ratio. (C) Serum IL-6 levels. (D) Serum TNF- α levels. (E) Serum ALT levels. The mice were treated with saline, MC3 or SM102 LNPs (nontargeting or Apt62:75), or SM102 anti-mouse CD4 mAb-conjugated LNPs. Data represent the mean±SD ( n = 4). Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test; ** p < 0.01.

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: Assessment of organ indices and systemic cytokine markers 6 h postinjection. (A) Liver-to-body weight ratio. (B) Spleen-to-body weight ratio. (C) Serum IL-6 levels. (D) Serum TNF- α levels. (E) Serum ALT levels. The mice were treated with saline, MC3 or SM102 LNPs (nontargeting or Apt62:75), or SM102 anti-mouse CD4 mAb-conjugated LNPs. Data represent the mean±SD ( n = 4). Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple comparisons test; ** p < 0.01.

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Saline

    eGFP expression in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells following transfection with SM102 LNPs functionalized with AutoNA-predicted aptamers (Apt62, Apt54, Apt72, Apt121) at a 100:1 ratio. Data represent the mean±SD ( n = 4). Statistical significance was determined using two-way ANOVA followed by Tukey’s multiple comparisons test; **** p < 0.0001.

    Journal: Drug Delivery

    Article Title: Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4⁺ T cells

    doi: 10.1080/10717544.2026.2637266

    Figure Lengend Snippet: eGFP expression in SUP-T1 (CD4⁺) and HSB2 (CD4⁻) cells following transfection with SM102 LNPs functionalized with AutoNA-predicted aptamers (Apt62, Apt54, Apt72, Apt121) at a 100:1 ratio. Data represent the mean±SD ( n = 4). Statistical significance was determined using two-way ANOVA followed by Tukey’s multiple comparisons test; **** p < 0.0001.

    Article Snippet: CD4 + SUPT-1 (Cat. No. CRL-1942) and CD4 - HSB-2 (Cat. No. CCL-120.1) human cell lines, Roswell Park Memorial Institute medium (RPMI-1640, Cat. No. 30-2001), and Iscove's modified Dulbecco's medium (IMDM, Cat. No. 30-2005) culture media were obtained from the American Type Culture Collection (Virginia, USA).

    Techniques: Expressing, Transfection